##gff-version 3
##sequence-region Q8IU80 1 811
Q8IU80	UniProtKB	Chain	1	811	.	.	.	ID=PRO_0000088696;Note=Transmembrane protease serine 6	
Q8IU80	UniProtKB	Topological domain	1	55	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Transmembrane	56	76	.	.	.	Note=Helical%3B Signal-anchor for type II membrane protein;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Topological domain	77	811	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Domain	84	209	.	.	.	Note=SEA;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00188	
Q8IU80	UniProtKB	Domain	213	336	.	.	.	Note=CUB 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00059	
Q8IU80	UniProtKB	Domain	335	452	.	.	.	Note=CUB 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00059	
Q8IU80	UniProtKB	Domain	457	489	.	.	.	Note=LDL-receptor class A 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00124	
Q8IU80	UniProtKB	Domain	490	526	.	.	.	Note=LDL-receptor class A 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00124	
Q8IU80	UniProtKB	Domain	530	567	.	.	.	Note=LDL-receptor class A 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00124	
Q8IU80	UniProtKB	Domain	577	811	.	.	.	Note=Peptidase S1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00274	
Q8IU80	UniProtKB	Active site	617	617	.	.	.	Note=Charge relay system;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Active site	668	668	.	.	.	Note=Charge relay system;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Active site	762	762	.	.	.	Note=Charge relay system;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Glycosylation	136	136	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Glycosylation	184	184	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Glycosylation	216	216	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Glycosylation	338	338	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Glycosylation	433	433	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Glycosylation	453	453	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Glycosylation	518	518	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IU80	UniProtKB	Disulfide bond	335	366	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	458	470	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	464	480	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	474	489	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	491	503	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	497	516	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	510	525	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	531	543	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	538	557	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	551	566	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	602	618	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	702	768	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	733	747	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Disulfide bond	758	787	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IU80	UniProtKB	Alternative sequence	1	9	.	.	.	ID=VSP_035562;Note=In isoform 2 and isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:12149247,ECO:0000303|PubMed:12975309,ECO:0000303|PubMed:15461802;Dbxref=PMID:12149247,PMID:12975309,PMID:15461802	
Q8IU80	UniProtKB	Alternative sequence	409	461	.	.	.	ID=VSP_008379;Note=In isoform 3. LCGLRILQPYAERIPVVATAGITINFTSQISLTGPGVRVHYGLYNQSDPCPGE->YHFLSSLWLPFLPPPPSLPSSTVTPSLEAQVPNLRGAARGASRGWGWCQACCP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q8IU80	UniProtKB	Alternative sequence	462	811	.	.	.	ID=VSP_008380;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q8IU80	UniProtKB	Alternative sequence	714	714	.	.	.	ID=VSP_035563;Note=In isoform 4. G->ALRADAVALFYGWRNQGSETCCC;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15461802;Dbxref=PMID:15461802	
Q8IU80	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_068665;Note=In IRIDA%3B does not undergo proteolytic processing%3B loss of activity. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22581667;Dbxref=dbSNP:rs199474803,PMID:22581667	
Q8IU80	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_068666;Note=In IRIDA%3B results in reduced inhibition of HAMP promoter. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19592582;Dbxref=dbSNP:rs267607121,PMID:19592582	
Q8IU80	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_064075;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B does not undergo proteolytic processing%3B impaired localization to the cell membrane%3B able to interact with HJV. Y->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20232450,ECO:0000269|PubMed:20704562,ECO:0000269|PubMed:25588876;Dbxref=dbSNP:rs1430692214,PMID:20232450,PMID:20704562,PMID:25588876	
Q8IU80	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_064076;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B reduced localization to the cell membrane%3B no effect on catalytic activity. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20232450,ECO:0000269|PubMed:25588876;Dbxref=dbSNP:rs776877803,PMID:20232450,PMID:25588876	
Q8IU80	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_036296;Note=In a breast cancer sample%3B somatic mutation. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs749106338,PMID:16959974	
Q8IU80	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_068667;Note=G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19818657;Dbxref=dbSNP:rs754848810,PMID:19818657	
Q8IU80	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_036297;Note=In a breast cancer sample%3B somatic mutation. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q8IU80	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_068668;Note=In IRIDA%3B does not undergo proteolytic processing%3B loss of activity. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22581667;Dbxref=dbSNP:rs199474802,PMID:22581667	
Q8IU80	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_072901;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B loss of catalytic activity%3B autoproteolytic and HJV processing are impaired. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=PMID:25156943	
Q8IU80	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_051841;Note=K->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19818657,ECO:0000269|PubMed:21643693;Dbxref=dbSNP:rs2235324,PMID:19818657,PMID:21643693	
Q8IU80	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_044434;Note=E->K;Dbxref=dbSNP:rs2235324	
Q8IU80	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_064077;Note=In IRIDA%3B no effect on HJV-mediated inhibition of HAMP transcription%3B no effect on localization to the cell membrane%3B no effect on catalytic activity%3B HJV processing is not affected. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20232450,ECO:0000269|PubMed:25588876;Dbxref=dbSNP:rs776180387,PMID:20232450,PMID:25588876	
Q8IU80	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_072902;Note=In IRIDA%3B no effect on HJV-mediated inhibition of HAMP transcription%3B no effect on catalytic activity%3B autoproteolytic and HJV processing are not affected. T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=dbSNP:rs1449962575,PMID:25156943	
Q8IU80	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_051842;Note=S->L;Dbxref=dbSNP:rs5995378	
Q8IU80	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_064078;Note=In IRIDA. S->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19708871,ECO:0000269|PubMed:20232450,ECO:0000269|PubMed:25156943;Dbxref=dbSNP:rs1373272804,PMID:19708871,PMID:20232450,PMID:25156943	
Q8IU80	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_072903;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B loss of catalytic activity%3B autoproteolytic and HJV processing are impaired. C->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=PMID:25156943	
Q8IU80	UniProtKB	Natural variant	418	418	.	.	.	ID=VAR_068669;Note=In IRIDA%3B does not undergo proteolytic processing%3B loss of activity. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22581667;Dbxref=dbSNP:rs199474804,PMID:22581667	
Q8IU80	UniProtKB	Natural variant	442	442	.	.	.	ID=VAR_044435;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B reduced localization to the cell membrane%3B altered catalytic activity%3B autoproteolytic processing is reduced but it retains the ability to process HJV%3B able to interact with HJV. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18408718,ECO:0000269|PubMed:19357398,ECO:0000269|PubMed:25588876;Dbxref=dbSNP:rs137853119,PMID:18408718,PMID:19357398,PMID:25588876	
Q8IU80	UniProtKB	Natural variant	446	446	.	.	.	ID=VAR_068670;Note=R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19818657;Dbxref=dbSNP:rs117576908,PMID:19818657	
Q8IU80	UniProtKB	Natural variant	510	510	.	.	.	ID=VAR_072904;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B loss of catalytic activity%3B autoproteolytic and HJV processing are impaired. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=PMID:25156943	
Q8IU80	UniProtKB	Natural variant	510	510	.	.	.	ID=VAR_064079;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B reduced localization to the cell membrane%3B loss of catalytic activity%3B no ability to process HJV. C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20232450,ECO:0000269|PubMed:25588876;Dbxref=PMID:20232450,PMID:25588876	
Q8IU80	UniProtKB	Natural variant	521	521	.	.	.	ID=VAR_072905;Note=In IRIDA. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=PMID:25156943	
Q8IU80	UniProtKB	Natural variant	521	521	.	.	.	ID=VAR_044436;Note=In IRIDA%3B reduced expression at the cell surface%3B partially retained in the Golgi apparatus%3B does not undergo proteolytic processing%3B able to interact with HJV%3B results in reduced inhibition of HAMP promoter. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18408718,ECO:0000269|PubMed:19357398;Dbxref=dbSNP:rs137853120,PMID:18408718,PMID:19357398	
Q8IU80	UniProtKB	Natural variant	522	522	.	.	.	ID=VAR_068671;Note=In IRIDA%3B reduced expression at the cell surface%3B partially retained in the Golgi apparatus%3B does not undergo proteolytic processing%3B able to interact with HJV%3B results in reduced inhibition of HAMP promoter. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19357398;Dbxref=dbSNP:rs387907018,PMID:19357398	
Q8IU80	UniProtKB	Natural variant	590	590	.	.	.	ID=VAR_072906;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B loss of catalytic activity%3B autoproteolytic and HJV processing are impaired. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=dbSNP:rs770897887,PMID:25156943	
Q8IU80	UniProtKB	Natural variant	597	597	.	.	.	ID=VAR_072907;Note=In IRIDA%3B slightly reduced HJV-mediated inhibition of HAMP transcription%3B loss of catalytic activity%3B autoproteolytic and HJV processing are significantly reduced. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=dbSNP:rs773272073,PMID:25156943	
Q8IU80	UniProtKB	Natural variant	603	603	.	.	.	ID=VAR_068672;Note=In IRIDA. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21618415;Dbxref=dbSNP:rs769083817,PMID:21618415	
Q8IU80	UniProtKB	Natural variant	605	605	.	.	.	ID=VAR_072908;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B loss of catalytic activity%3B autoproteolytic and HJV processing are impaired. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=PMID:25156943	
Q8IU80	UniProtKB	Natural variant	606	606	.	.	.	ID=VAR_072909;Note=In IRIDA%3B reduced HJV-mediated inhibition of HAMP transcription%3B loss of catalytic activity%3B autoproteolytic and HJV processing are impaired. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=PMID:25156943	
Q8IU80	UniProtKB	Natural variant	623	623	.	.	.	ID=VAR_072910;Note=In IRIDA. S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25156943;Dbxref=PMID:25156943	
Q8IU80	UniProtKB	Natural variant	674	674	.	.	.	ID=VAR_068673;Note=L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19818657;Dbxref=PMID:19818657	
Q8IU80	UniProtKB	Natural variant	736	736	.	.	.	ID=VAR_051843;Note=V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12975309,ECO:0000269|PubMed:19818657;Dbxref=dbSNP:rs855791,PMID:12975309,PMID:19818657	
Q8IU80	UniProtKB	Natural variant	763	763	.	.	.	ID=VAR_051844;Note=G->D;Dbxref=dbSNP:rs11703011	
Q8IU80	UniProtKB	Natural variant	765	765	.	.	.	ID=VAR_068674;Note=In IRIDA%3B severely reduced proteolytic processing%3B loss of activity. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22581667;Dbxref=dbSNP:rs199474805,PMID:22581667	
Q8IU80	UniProtKB	Natural variant	774	774	.	.	.	ID=VAR_044437;Note=In IRIDA. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18408718;Dbxref=dbSNP:rs776069764,PMID:18408718	
Q8IU80	UniProtKB	Natural variant	795	795	.	.	.	ID=VAR_068675;Note=V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19818657;Dbxref=dbSNP:rs139105452,PMID:19818657	
Q8IU80	UniProtKB	Mutagenesis	576	576	.	.	.	Note=Does not undergo proteolytic processing. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22581667;Dbxref=PMID:22581667	
Q8IU80	UniProtKB	Mutagenesis	762	762	.	.	.	Note=Does not undergo proteolytic processing. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20518742,ECO:0000269|PubMed:22581667;Dbxref=PMID:20518742,PMID:22581667	
Q8IU80	UniProtKB	Sequence conflict	116	116	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
